Navalign LLC’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $877K | Buy |
2,163
+21
| +1% | +$8.51K | 0.24% | 69 |
|
|
2025
Q1 | $1.07M | Buy |
2,142
+48
| +2% | +$23.9K | 0.3% | 56 |
|
|
2024
Q4 | $1.09M | Buy |
2,094
+31
| +2% | +$16.1K | 0.32% | 54 |
|
|
2024
Q3 | $1.28M | Buy |
2,063
+32
| +2% | +$19.8K | 0.38% | 48 |
|
|
2024
Q2 | $1.12M | Buy |
2,031
+143
| +8% | +$79.1K | 0.35% | 50 |
|
|
2024
Q1 | $1.1M | Buy |
1,888
+149
| +9% | +$86.6K | 0.36% | 51 |
|
|
2023
Q4 | $923K | Sell |
1,739
-212
| -11% | -$113K | 0.32% | 61 |
|
|
2023
Q3 | $987K | Buy |
1,951
+51
| +3% | +$25.8K | 0.37% | 54 |
|
|
2023
Q2 | $991K | Sell |
1,900
-41
| -2% | -$21.4K | 0.4% | 45 |
|
|
2023
Q1 | $1.12M | Buy |
1,941
+77
| +4% | +$44.4K | 0.47% | 38 |
|
|
2022
Q4 | $1.03M | Sell |
1,864
-29
| -2% | -$16K | 0.42% | 47 |
|
|
2022
Q3 | $960K | Buy |
1,893
+35
| +2% | +$17.8K | 0.43% | 41 |
|
|
2022
Q2 | $1.01M | Sell |
1,858
-20
| -1% | -$10.9K | 0.44% | 41 |
|
|
2022
Q1 | $977K | Sell |
1,878
-27
| -1% | -$14K | 0.41% | 48 |
|
|
2021
Q4 | $1.27M | Sell |
1,905
-54
| -3% | -$36K | 0.51% | 37 |
|
|
2021
Q3 | $1.12M | Sell |
1,959
-460
| -19% | -$263K | 0.47% | 44 |
|
|
2021
Q2 | $1.22M | Buy |
2,419
+29
| +1% | +$14.6K | 0.52% | 42 |
|
|
2021
Q1 | $1.09M | Buy |
+2,390
| New | +$1.09M | 0.48% | 44 |
|